Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations

References

• UNAIDS. AIDS by the numbers – AIDS is not over but it can be. 2016.
   Google Scholar
• Centers for disease control and prevention. Diagnoses of HIV infection in the United States and dependent areas. HIV Surveillance Report. 2015;27.
   Google Scholar
• UNAIDS. UNAIDS strategy 2016–2021. 2015.
   Google Scholar
• Frieden TR, Foti KE, Mermin J. Applying public health principles to the HIV epidemic-how are we doing? N Engl J Med. 2015;373:2281–2287.
   PubMed Web of Science ®Google Scholar
• Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493–505.
   PubMed Web of Science ®Google Scholar
• Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–434.
   PubMed Web of Science ®Google Scholar
• Rodger AJ, Lampe FC, Grulich AE, et al. Transmission risk behaviour at enrolment in participants in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med. 2015;16(Suppl 1):64–76.
   PubMed Web of Science ®Google Scholar
• Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner Is using suppressive antiretroviral therapy. JAMA. 2016;316:171–181.
   PubMed Web of Science ®Google Scholar
• Smith DK, Herbst JH, Zhang X, et al. Condom effectiveness for HIV prevention by consistency of use among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2015;68:337–344.
   PubMed Web of Science ®Google Scholar
• Shuper PA, Pillay S, MacDonald S, et al. One in 4 HIV-positive South Africans awaiting ART initiation report condomless sex with a serodiscordant partner. J Acquir Immune Defic Syndr. 2016;72:77–79.
   PubMed Web of Science ®Google Scholar
• Crosby R, Yarber WL, Sanders SA, et al. Slips, breaks and ‘falls’: condom errors and problems reported by men attending an STD clinic. Int J STD AIDS. 2008;19:90–93.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Chaillon A, Morris SR, et al. HIV infection rates and risk behavior among young men undergoing community-based testing in San Diego. Sci Rep. 2016;6:25927
   PubMed Web of Science ®Google Scholar
• Kiene SM, Simbayi LC, Abrams A, et al. High rates of unprotected sex occurring among HIV-positive individuals in a daily diary study in South Africa: the role of alcohol use. J Acquir Immune Defic Syndr. 2008;49:219–226.
   PubMed Web of Science ®Google Scholar
• Perry NS, Taylor SW, Elsesser S, et al. The predominant relationship between sexual environment characteristics and HIV-serodiscordant condomless anal sex among HIV-positive men who have sex with men (MSM). AIDS Behav. 2016;20:1228–1235.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Marks G, Mansergh G, et al. Age-related risk for HIV infection in men who have sex with men: examination of behavioral, relationship, and serostatus variables. AIDS Educ Prev. 2000;12:405–415.
   PubMed Web of Science ®Google Scholar
• Patel P, Borkowf CB, Brooks JT, et al. Estimating per-act HIV transmission risk: a systematic review. AIDS. 2014;28:1509–1519.
   PubMed Web of Science ®Google Scholar
• Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res. 2010;85:276–285.
   PubMed Web of Science ®Google Scholar
• Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:305–310.
   PubMed Web of Science ®Google Scholar
• Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009;(2):CD003362.
   PubMed Web of Science ®Google Scholar
• Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis. 2009;9:118–129.
   PubMed Web of Science ®Google Scholar
• Chan SK, Thornton LR, Chronister KJ, et al. Likely female-to-female sexual transmission of HIV -Texas, 2012. MMWR Morb Mortal Wkly Rep. 2014;63:209–212.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Marks G, Liau A, et al. Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis. AIDS. 2009;23:1617–1629.
   PubMed Web of Science ®Google Scholar
• Scott HM, Vittinghoff E, Irvin R, et al. Age, race/ethnicity, and behavioral risk factors associated with per contact risk of HIV infection among men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2014;65:115–121.
   PubMed Web of Science ®Google Scholar
• Giannou FK, Tsiara CG, Nikolopoulos GK, et al. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res. 2016;16:489–499.
   PubMed Web of Science ®Google Scholar
• Hughes JP, Baeten JM, Lingappa JR, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis. 2012;205:358–365.
   PubMed Web of Science ®Google Scholar
• Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002;(1):CD003255.
   PubMedGoogle Scholar
• Crosby RA, Charnigo RA, Weathers C, et al. Condom effectiveness against non-viral sexually transmitted infections: a prospective study using electronic daily diaries. Sex Transm Infect. 2012;88:484–489.
   PubMed Web of Science ®Google Scholar
• Mujugira A, Celum C, Coombs RW, et al. HIV transmission risk persists during the first 6 months of antiretroviral therapy. J Acquir Immune Defic Syndr. 2016;72:579–584.
   PubMed Web of Science ®Google Scholar
• Mujugira A, Coombs RW, Heffron R, et al. Seminal HIV-1 RNA detection in heterosexual African men initiating antiretroviral therapy. J Infect Dis. 2016;214:212–215.
   PubMed Web of Science ®Google Scholar
• Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–839.
   PubMed Web of Science ®Google Scholar
• Oldenburg CE, Barnighausen T, Tanser F, et al. Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa. Clin Infect Dis. 2016;63:548–554.
   PubMed Web of Science ®Google Scholar
• McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53–60.
   PubMed Web of Science ®Google Scholar
• Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410.
   PubMed Web of Science ®Google Scholar
• Straube T. Meet the Man Who Got HIV While on Daily PrEP. POZ [Internet]. 2016. Available from: https://www.poz.com/article/meet-man-got-hiv-daily-prep.
   Google Scholar
• Knox DCT, Darrell H, Harrigan P, Richard, et al. HIV-1 infection with multiclass resistance despite preexposure prophylaxis (PreP). Conference on Retroviruses and Opportunistic Infections 2016 2016; Boston, MA, USA.
   Google Scholar
• Grossman H, Anderson P, Grant R, Gandhi M, Mohri H, Markowitz M. Newly acquired HIV-1 infection with multi-drug resistant (MDR) HIV-1 in a patient on TDF/FTC-based PrEP. HIV Research for Prevention 2016 conference. 2016. Chicago, IL, USA. Abstract OA03.06LB.
   Google Scholar
• Celum C, Hallett TB, Baeten JM. HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact. J Infect Dis. 2013;208:189–191.
   PubMed Web of Science ®Google Scholar
• Abbas UL, Glaubius R, Mubayi A, et al. Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa. J Infect Dis. 2013;208:224–234.
   PubMed Web of Science ®Google Scholar
• Mugwanya KK, Donnell D, Celum C, et al. Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis. Lancet Infect Dis. 2013;13:1021–1028.
   PubMed Web of Science ®Google Scholar
• Suzan-Monti M, Lorente N, Demoulin B, et al. Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey. J Int AIDS Soc. 2016;19:20095.
   PubMed Web of Science ®Google Scholar
• Mujugira A, Celum C, Ngure K, et al. Antiretroviral therapy initiation is not associated with risky sexual behavior among heterosexual human immunodeficiency virus-infected persons in serodiscordant partnerships. Sex Transm Dis. 2017;44:57–61.
   PubMed Web of Science ®Google Scholar
• Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224–236.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV – United States, 2016. CDC Stacks [Internet]. 2016. Available from: https://stacks.cdc.gov/view/cdc/38856.
   Google Scholar
• Cresswell F, Waters L, Briggs E, et al. UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015. Int J STD AIDS. 2016;27:713–738.
   PubMed Web of Science ®Google Scholar
• Jain S, Oldenburg CE, Mimiaga MJ, et al. Subsequent HIV infection among men who have sex with men who used non-occupational post-exposure prophylaxis at a Boston community health center: 1997-2013. AIDS Patient Care STDS. 2015;29:20–25.
   PubMed Web of Science ®Google Scholar
• Poynten IM, Jin F, Mao L, et al. Nonoccupational postexposure prophylaxis, subsequent risk behaviour and HIV incidence in a cohort of Australian homosexual men. AIDS. 2009;23:1119–1126.
   PubMed Web of Science ®Google Scholar
• Pierce AB, El-Hayek C, McCarthy D, et al. Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system. Sex Health. 2016;14:179–187.
   Web of Science ®Google Scholar
• Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342:921–929.
   PubMed Web of Science ®Google Scholar
• Baeten JM, Kahle E, Lingappa JR, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med. 2011;3:77ra29.
   PubMed Web of Science ®Google Scholar
• Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308:387–402.
   PubMed Web of Science ®Google Scholar
• Politch JA, Mayer KH, Welles SL, et al. Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men. AIDS. 2012;26:1535–1543.
   PubMed Web of Science ®Google Scholar
• Sturmer M, Doerr HW, Berger A, et al. Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?. Antivir Ther (Lond). 2008;13:729–732.
   PubMed Web of Science ®Google Scholar
• Ferraretto X, Estellat C, Damond F, et al. Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy. PLoS One. 2014;9:e88922.
   PubMed Web of Science ®Google Scholar
• Gianella S, Haubrich R, Morris SR. Suppressed but still infectious. Future Virol. 2013;8:1037–1040.
   Web of Science ®Google Scholar
• Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS. 2001;15:621–627.
   PubMed Web of Science ®Google Scholar
• Conroy AA, Gamarel KE, Neilands TB, et al. Partner reports of HIV viral suppression predict sexual behavior in serodiscordant male couples. J Acquir Immune Defic Syndr. 2016;73:e31–e33.
   PubMed Web of Science ®Google Scholar
• Landovitz RJ, Tran TT, Cohn SE, et al. HIV transmission risk behavior in a cohort of HIV-Infected Treatment-Naïve Men and Women in the United States . AIDS Behav. 2016;20:2983–2995.
   PubMed Web of Science ®Google Scholar
• Ngure K, Vusha S, Mugo N, et al. “I never thought that it would happen …” Experiences of HIV seroconverters among HIV-discordant partnerships in a prospective HIV prevention study in Kenya. AIDS Care. 2016;28:1586–1589.
   PubMed Web of Science ®Google Scholar
• World Health Organization, Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections – 2008. 2012.
   Google Scholar
• Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10:e0143304.
   PubMed Web of Science ®Google Scholar
• Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis. 2008;35:946–959.
   PubMed Web of Science ®Google Scholar
• Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS One. 2008;3:e2230.
   PubMed Web of Science ®Google Scholar
• van de Wijgert JH, Morrison CS, Brown J, et al. Disentangling contributions of reproductive tract infections to HIV acquisition in African women. Sex Transm Dis. 2009;36:357–364.
   PubMed Web of Science ®Google Scholar
• Magaret AS, Mujugira A, Hughes JP, et al. Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples. Clin Infect Dis. 2016;62:456–461.
   PubMed Web of Science ®Google Scholar
• Braunstein SL, van de Wijgert JH, Nash D. HIV incidence in sub-Saharan Africa: a review of available data with implications for surveillance and prevention planning. AIDS Rev. 2009;11:140–156.
   PubMed Web of Science ®Google Scholar
• Tobian AA, Ssempijja V, Kigozi G, et al. Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS. 2009;23:1589–1594.
   PubMed Web of Science ®Google Scholar
• Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362:427–439.
   PubMed Web of Science ®Google Scholar
• Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med. 2008;358:1560–1571.
   PubMed Web of Science ®Google Scholar
• Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:2109–2119.
   PubMed Web of Science ®Google Scholar
• Gray RH, Wawer MJ. Reassessing the hypothesis on STI control for HIV prevention. Lancet. 2008;371:2064–2065.
   PubMed Web of Science ®Google Scholar
• Warner L, Stone KM, Macaluso M, et al. Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. 2006;33:36–51.
   PubMed Web of Science ®Google Scholar
• Shlay JC, McClung MW, Patnaik JL, et al. Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sex Transm Dis. 2004;31:154–160.
   PubMed Web of Science ®Google Scholar
• Sanchez J, Campos PE, Courtois B, et al. Prevention of sexually transmitted diseases (STDs) in female sex workers: prospective evaluation of condom promotion and strengthened STD services. Sex Transm Dis. 2003;30:273–279.
   PubMed Web of Science ®Google Scholar
• Warner L, Newman DR, Austin HD, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol. 2004;159:242–251.
   PubMed Web of Science ®Google Scholar
• Musinguzi G, Bastiaens H, Matovu JK, et al. Barriers to condom use among high risk men who have sex with men in Uganda: a qualitative study. PLoS One. 2015;10:e0132297
   PubMed Web of Science ®Google Scholar
• Ostergren JE, Rosser BR, Horvath KJ. Reasons for non-use of condoms among men who have sex with men: a comparison of receptive and insertive role in sex and online and offline meeting venue. Cult Health Sex. 2011;13:123–140.
   PubMed Web of Science ®Google Scholar
• Kintu A, Hankinson SE, Balasubramanian R, et al. Sexual relationships outside primary partnerships and abstinence are associated with lower adherence and adherence gaps: data from the Partners PrEP Ancillary Adherence Study. J Acquir Immune Defic Syndr. 2015;69:36–43.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach. 2016.
   Google Scholar
• Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20:73–83.
   PubMed Web of Science ®Google Scholar
• Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185:45–52.
   PubMed Web of Science ®Google Scholar
• Chin-Hong PV, Husnik M, Cranston RD, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009;23:1135–1142.
   PubMed Web of Science ®Google Scholar
• Auvert B, Lissouba P, Cutler E, et al. Association of oncogenic and nononcogenic human papillomavirus with HIV incidence. J Acquir Immune Defic Syndr. 2010;53:111–116.
   PubMed Web of Science ®Google Scholar
• Jin F, Prestage GP, Imrie J, et al. Anal sexually transmitted infections and risk of HIV infection in homosexual men. J Acquir Immune Defic Syndr. 2010;53:144–149.
   PubMed Web of Science ®Google Scholar
• Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010;53:537–543.
   PubMed Web of Science ®Google Scholar